Accrued Expenses and Other Liabilities (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Accrued Expenses and Other Liabilities
Accrued marketing expenses	$ 1,013,497
Other expenses	313,254	$ 426,025
Accrued preclinical and clinical trial expenses	405,792	953,252
Compensation and related benefits	332,641	491,191
Accrued manufacturing expenses	97,877	6,133
Accrued franchise tax	38,800	40,000
Accrued expenses and other current liabilities	$ 2,201,861	$ 1,916,601